NCT00234455View on ClinicalTrials.gov

A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.

PHASE2CompletedINTERVENTIONAL

Enrollment

86

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

October 31, 2002

Study Completion Date

April 30, 2007

Conditions

Coronary Artery Disease

Interventions

DEVICE

drug eluting-stent

PCI

DEVICE

drug-eluting stent

PCI

Trial Locations (1)

I-20145

Centre Cuore Columbus, Milan

Sponsors

Lead Sponsor

Cordis Corporation

All Listed Sponsors

lead

Cordis Corporation

INDUSTRY

NCT00234455 - A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions. | Biotech Hunter | Biotech Hunter